Back to archive

Bactiguard Holding AB’s interim report third quarter 2025

23 October 2025, 07:00 CET Regulatory

Continued profitability and clinical evidence supporting future growth

Continued profitability and clinical evidence supporting future growth

Third quarter 2025 (July – September)

The period January – September 2025

Christine Lind, CEO of Bactiguard comments:

“The profitability trend continued during the third quarter with an EBITDA of SEK 5.3 million (Q3 2024: SEK 9.9 million). Revenues amounted to SEK 48.4 (Q3 2024: SEK 73.9 million) with license revenues of SEK 29.9 million (Q3 2024: 47.5 million). The comparison is impacted by a weaker USD and high base from last year. The Wound Management portfolio revenues totalled SEK 15.6 million (Q3 2024: SEK 17.9 million) with continued growth in Hydrocyn aqua, but a decline in sutures.”

Bactiguard Holding AB’s (publ) interim report for the third quarter 2025 is available at https://ir.bactiguard.com/

This information is information that Bactiguard Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out below, 2025-10-23 at 07:00 CET.

For further information, please contact:
Patrick Bach, CFO +46 761 295 911
Nina Nornholm, Head of Communications & Investor Relations +46 708 550 356

To participate in the audiocast, please use this link: https://ir.bactiguard.com/report/q3-2025/
To participate only by conference call, please register on the link above. Questions can be asked either in writing via the audiocast or orally if you attend the conference call.

For further information, please contact:
Patrick Bach, CFO +46 761 295 911
Nina Nornholm, Head of Communications & Investor Relations +46 708 550 356

To participate in the audiocast, please use this link: https://ir.bactiguard.com/report/q3-2025/
To participate only by conference call, please register on the link above. Questions can be asked either in writing via the audiocast or orally if you attend the conference call.

Media & Investor Relations

  • Patrick Bach

    Patrick Bach

    CFO

    +46 (0) 76 129 59 11

This video is hosted by YouTube (Google). When the video loads, YouTube may set cookies and process personal data, such as your IP address.

If you accept, YouTube videos will play anywhere on this website without asking again for 10 days. You can withdraw your consent at any time under Cookies at the bottom of the page.

Read more in our cookie policy

The audiocast is hosted by Inderes, which provides the technical platform for Bactiguard’s financial presentations. When the audiocast loads, Inderes may set cookies and process personal data, such as your IP address.

If you accept, Inderes audiocasts will play anywhere on this website without asking again for 10 days. You can withdraw your consent at any time under Cookies at the bottom of the page.

Read more in our cookie policy

Cookies

You have allowed YouTube videos on this website. Your consent is valid until: .

If you withdraw your consent, YouTube videos will no longer load until you accept again. Cookies that YouTube has already set can be deleted in your browser settings.

You have allowed Inderes audiocasts on this website. Your consent is valid until: .

If you withdraw your consent, Inderes audiocasts will no longer load until you accept again. Cookies that Inderes has already set can be deleted in your browser settings.

Read more in our cookie policy